Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00483626
What this trial is testing

Hemodynamic Response After Six Months of Sildenafil

Who this might be right for
Pulmonary Arterial Hypertension
University of Chile 27
Testing effectiveness (Phase 2)Study completedNCT06137742
What this trial is testing

Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 97
Post-approval studies (Phase 4)Study completedNCT01268553
What this trial is testing

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

Who this might be right for
Pulmonary Arterial Hypertension
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 6
Not applicableUnknownNCT04972656
What this trial is testing

Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Nanjing First Hospital, Nanjing Medical University 420
Not applicableUnknownNCT03205085
What this trial is testing

Determinants of Right Heart Remodeling in Patients With CTEPH or PAH

Who this might be right for
Chronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
Centre Chirurgical Marie Lannelongue 150
Not applicableWithdrawnNCT01645826
What this trial is testing

Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial HypertensionPrimary Pulmonary HypertensionPulmonary Arterial Hypertension+1 more
University of South Florida
Post-approval studies (Phase 4)UnknownNCT03835676
What this trial is testing

Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Magdi H. Yacoub 30
Not applicableStudy completedNCT01406327
What this trial is testing

Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 900
Testing effectiveness (Phase 2)Ended earlyNCT01725269
What this trial is testing

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 17
Early research (Phase 1)Study completedNCT00435331
What this trial is testing

6R-BH4 Pulmonary Arterial Hypertension Study

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University 14
Not applicableEnrolling By InvitationNCT07558460
What this trial is testing

Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Istanbul University - Cerrahpasa 32
Testing effectiveness (Phase 2)Study completedNCT02290613
What this trial is testing

Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Heidelberg University 38
Large-scale testing (Phase 3)Study completedNCT00325403
What this trial is testing

FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
United Therapeutics 349
Not applicableLooking for participantsNCT06954727
What this trial is testing

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization

Who this might be right for
Pulmonary HypertensionPulmonary Embolism (Diagnosis)Pulmonary Arterial Hypertension+1 more
China-Japan Friendship Hospital 10,000
Early research (Phase 1)Study completedNCT02955420
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Berlin Cures GmbH 74
Early research (Phase 1)Study completedNCT03145298
What this trial is testing

ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Cedars-Sinai Medical Center 26
Not applicableStudy completedNCT02391441
What this trial is testing

Ventricular Reversed Remodeling After LTX in PAH Patients

Who this might be right for
Pulmonary Arterial Hypertension
University Medical Center Groningen 17
Testing effectiveness (Phase 2)Study completedNCT00352482
What this trial is testing

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
National Heart, Lung, and Blood Institute (NHLBI) 20
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Ended earlyNCT01077297
What this trial is testing

Tezosentan in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Idorsia Pharmaceuticals Ltd. 3
Next Page